Data Integrity Issues In Bioequivalence Studies

Summary

Nilufer Tampal, PhD, Acting Deputy Director of the Office of CDER's Director of the Division of Generic Drug ... Former Deputy Commissioner of USFDA says that while qualitatively there has been an improvement in Victoria Keck, MS, VMD, Division of Clinical Review, discusses types of In this second video of the mini-series on Quality System Labeling in Redica Systems, Senior GMP Quality Expert, Jerry Chapman ... Cynthia F. Kleppinger from CDER's Office of Scientific Investigations describes what a In recent years, FDA has increasingly observed CGMP violations involving Complex workflows, inefficient and unreliable manual processes, lack of training on technical tools among personnel, and ... Jean Mulinde from CDER's Office of Scientific Investigations describes the casic characteristics of clinical trials of quality. All India Drugs Control Officers Confederation.